Frequently Asked Questions
What is Cipla Ltd?
Cipla Limited is an India-based company, which is primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The Company's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa, and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 47 manufacturing sites.
What is CAGR?
CAGR stands for Compound Annual Growth Rate. In the stock market, it's a useful metric to measure the compound annual growth rate of an investment over a specific period of time, assuming the profits are reinvested at the end of each year. CAGR shows how much an investment grows each year on average.
What is the 3 year, 5 year and 10 Year CAGR (annualized return) of Cipla Ltd?
CAGR (Compound Annual Growth Rate) of Cipla Ltd is as follows:
- 3 Year CAGR: 9.86%
- 5 Year CAGR: 14.28%
- 10 Year CAGR: 9.02%
What is the 1 year return of Cipla Ltd?
In the past 1 year, Cipla Ltd has given a return of -8.38%.
How often the data is updated on this page?
The Current Market Price (CMP) and CAGR data are updated every 15 minutes during market hours. However, the current month's and current year's returns are updated daily after the market closes.